|
Show Me the Data®: Evidence-Based Strategies to Leverage Immunogenicity in Hepatocellular Carcinoma
Target Audience
This educational program is directed toward medical oncologists, surgical oncologists, and radiation oncologists interested in the treatment of HCC. Hepatologists, gastroenterologists, nurse practitioners, physician assistants, nurses, and other health care professionals involved in the treatment and management of patients with HCC will also be invited to participate.
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in hepatocellu... |
|
Improving Liver Cancer Screening in Rural and Underserved Communities: Early Detection for Better Patient Outcomes
Target Audience
This activity is designed specifically for primary care clinicians, registered nurses, and advanced practice registered nurses who care for patients from rural and underserved areas.
Program Overview
Hepatocellular carcinoma (HCC) is one of the most rapidly increasing cancers in the United States, with an incidence rate that has more than tripled since 1980. While the rate of new HCC cases in urban areas has declined in recent years, it has increased steadily in rural area... |